Chemring Sensors and Electronic Systems and Smiths Detection have each won a potential 10-year contract from the U.S. Army to develop platforms designed to detect aerosols, threat vapors and other chemical agents.

According to FedBizOpps, Chemring received a potential $838.5M contract and Smiths Detection a potential $667.3M contract under the XM12 Aerosol & Vapor Chemical Agent Detector program.

Luxfer, the most trusted name for high-pressure gas cylinders worldwide and the world’s largest manufacturer of high-pressure composite and aluminium cylinders, showcased several of their highly acclaimed ECLIPSE cylinders on Interspiro’s stand (D71) at the Emergency Services Show (ESS) which took place at Birmingham NEC on 19/20th September.

Birmingham NEC on 19/20th September. https://www.emergencyuk.com

Interspiro, which develops premium respiratory protection and equipment for firefighting, emergency escape, diving and rescue operations, has been using Luxfer self-contained breathing apparatus (SCBA) and life-support cylinders for over 15 years. The company supplies military, police, industries, shipping companies and rescue services all over the world with exceptional products for extreme situations. Luxfer is the world’s most widely used cylinder brand for these applications, with their products designed and tested to meet or exceed all applicable global standards.

On 14 June 2018, DroneShield Ltd (ASX:DRO) (“DroneShield\" or the “Company”) advised the market that it had received a $3,200,000 order for 70 DroneGunsTM for use by a Middle Eastern Ministry of Defence. The announcement stated that the Company’s ability to fulfil the order was subject to approval by the relevant U.S. regulator, and that there were no guarantees that the approval for that particular order would be granted. The Company is pleased to advise that the relevant U.S. governmental approval has now been granted.

Chemring's US based subsidiary, Chemring Sensors and Electronic Systems, has been down selected as one of the suppliers on the first stream of the Next Generation Chemical Detector (NGCD1).

The National Library of Medicine ToxTutor, a self-paced tutorial covering key principles of toxicology for users of the National Library of Medicine (NLM) chemical and toxicology databases, has recently added new content and topics to it's every growing catalogue.

Alluviam has recently announced the release of the HazMasterG3, adding adaptive, mission specific CBRNE UI, and other advanced tools.

Changing mission requirements, from responding to improvised warfare agent contamination in Syria, site exploitation of clandestine labs, or responding to hazmat incidents all require unique tools and techniques to successfully prosecute these scenarios. With HazMasterG3’s new release, the system can rapidly adapt to these and other situations by dynamically adapting the user interface to meet the needs of any mission scenario

Public Health England (PHE) confirmed on September 8th that an individual had been diagnosed with Monkeypox in the UK, the first time such a diagnosis has been made.

Monkeypox is a rare infection and does not spread easily between individuals and PHE has made sure to issue information to this effect.

Bertin Technologies has been selected, in a consortium with Thales CS, by the Ministry of the Armed Forces for the upstream research market “Platform for the Integration of Innovative Technologies in the Domain of Biological and Chemical Analysis “(PI ABC),

Chemring Sensors and Electronic Systems, has been notified that it has been down selected as one of the suppliers on the first stream of the Next Generation Chemical Detector

Rigaku Analytical Devices unveils new handheld Raman analyser to redefine handheld 1064nm Raman for chemical threat identification

Sarcos Robotics announced a $30M Series B funding raise to help advance the deployment of its Guardian S mobile IoT inspection and surveillance robot, as well as prepare for the launch of the commercial versions of its autonomously powered, full-body industrial exoskeleton Guardian XO product line.

Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced on friday that it was awarded an Other Transaction Agreement (OTA) to support the Joint Project Manager Medical Countermeasure Systems (JPM-MCS) for advanced biologics manufacturing services—specifically, to manufacture an anti-Ebola monoclonal antibody (mAb).

The award was made possible through collaborative funding between JPEO CBRND and the Defense Advanced Research Projects Agency (DARPA). The antibody, designated mAb114, was developed at the Vaccine Research Center (VRC), part of the National Institute of Allergy and Infectious Diseases (NIAID) with the National Institutes of Health, in part through funding previously provided by DARPA. The VRC is a collaborator with JPM-MCS, DARPA, and Ology Bioservices on this program. Including optional work, the agreement has a value of $8.4 million.